Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.35 in the second quarter of fiscal 2025, up 5.7% year over year. The figure topped the ...

BD is considering a share swap deal with smaller diagnostics firms, such as Waters Corporation, Qiagen and Revvity. Under this structure, BD would merge the Life Sciences unit with a listed entity ...

Waters Corporation (NYSE: WAT) and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, ...